Document is current
Any future updates will be listed below
-
Authors
Ryman, Josiah http://orcid.org/0000-0002-7692-4432
Weaver, Jessica http://orcid.org/0000-0002-9861-3328
Hu, Tianyan
Weinberger, Daniel M.
Yee, Ka Lai
Sachs, Jeffrey R. http://orcid.org/0000-0001-5725-558X
-
Funding
Funding for this research was provided by:
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Bill and Melinda Gates Foundation (OPP1176267)
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
- License Information
-
More Information
Article History
Received: 3 March 2022
Accepted: 8 September 2022
First Online: 7 November 2022
Competing interests
: JR, JW, TH, KLY, and JRS are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and own stock and restricted stock units in Merck & Co., Inc., Rahway, NJ, USA. DMW has received consulting fees from Pfizer, Merck, GSK, Affinivax, and Matrivax for work separate from this manuscript and is PI on research grants from Pfizer and Merck to Yale University for work unrelated to this manuscript.
